Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads

By Maggie Fick and Stine Jacobsen COPENHAGEN, July 24 (Reuters) – Novo Nordisk said on Friday it is seeking a preliminary U.S. court injunction to immediately block obesity and diabetes drug

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)